{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:09:35Z","timestamp":1792894175720,"version":"4.5.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,7]]},"abstract":"<jats:p>Breast adenoid cystic carcinoma (ACC) is a primary breast carcinoma that, like salivary gland ACC, displays the t(6;9) translocation resulting in the <jats:italic toggle=\"yes\">MYB-NFIB<\/jats:italic> gene fusion and immunopositivity for MYB by immunohistochemistry (IHC). However, it is not well established whether MYB immunoreactivity or rearrangement can be used to support a diagnosis of ACC in a malignant basaloid or benign cribriform breast lesion. Whole sections of primary breast ACC (n=11), collagenous spherulosis (CS; n=7), and microglandular adenosis (MGA; n=5) and tissue microarrays containing 16 basal-like, triple-negative breast carcinomas (TNBC) were labeled for MYB by IHC and underwent <jats:italic toggle=\"yes\">MYB<\/jats:italic> fluorescence in situ hybridization using a break-apart probe. Strong, diffuse nuclear MYB labeling was seen in 100% ACC compared with no cases of basal-like TNBC, CS, or MGA (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.0001). Any degree of nuclear MYB labeling was seen in 100% ACC compared with 54% of all other cases (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.007), with any labeling seen in 71% CS, 63% basal-like TNBC, and 0% MGA. <jats:italic toggle=\"yes\">MYB<\/jats:italic> rearrangement was detected in 89% (8\/9) of evaluable ACC compared with 4% (1\/26) of all other evaluable cases (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.0001), with a rearrangement detected in 1 (7%; n=1\/15) evaluable basal-like TNBC. Strong, diffuse nuclear labeling for MYB is more sensitive than <jats:italic toggle=\"yes\">MYB<\/jats:italic> fluorescence in situ hybridization for breast ACC and can be used to support a diagnosis of ACC in a cribriform or basaloid lesion in the breast. However, weak and focal labeling should be interpreted with caution as it can be seen in other benign cribriform and malignant basaloid lesions.<\/jats:p>","DOI":"10.1097\/pas.0000000000000878","type":"journal-article","created":{"date-parts":[[2017,5,12]],"date-time":"2017-05-12T13:02:23Z","timestamp":1494594143000},"page":"973-979","source":"Crossref","is-referenced-by-count":69,"title":["MYB Labeling by Immunohistochemistry Is More Sensitive and Specific for Breast Adenoid Cystic Carcinoma than MYB Labeling by FISH"],"prefix":"10.1097","volume":"41","author":[{"given":"Justin S.","family":"Poling","sequence":"first","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raluca","family":"Yonescu","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea P.","family":"Subhawong","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajni","family":"Sharma","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedram","family":"Argani","sequence":"additional","affiliation":[{"name":"Pathology"},{"name":"Oncology, The Johns Hopkins Hospital, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Ning","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Cimino-Mathews","sequence":"additional","affiliation":[{"name":"Pathology"},{"name":"Oncology, The Johns Hopkins Hospital, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230922","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1002\/cncr.10455","article-title":"Adenoid cystic carcinoma of the breast: molecular markers, treatment, and clinical outcome","volume":"94","author":"Arpino","year":"2002","journal-title":"Cancer"},{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/path.2407","article-title":"Refinement of breast cancer classification by molecular characterization of histological special types","volume":"216","author":"Weigelt","year":"2008","journal-title":"J Pathol"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1056\/NEJMra1001389","article-title":"Triple-negative breast cancer","volume":"363","author":"Foulkes","year":"2010","journal-title":"N Engl J Med"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S1368-8375(02)00007-6","article-title":"Carcinoma of the parotid and submandibular glands\u2014a study of survival in 2465 patients","volume":"38","author":"Wahlberg","year":"2002","journal-title":"Oral Oncol"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"R54","DOI":"10.1186\/bcr2613","article-title":"Adenoid cystic carcinoma of the breast in the United States (1977 to 2006): a population-based cohort study","volume":"12","author":"Ghabach","year":"2010","journal-title":"Breast Cancer Res"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"18740","DOI":"10.1073\/pnas.0909114106","article-title":"Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck","volume":"106","author":"Persson","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/modpathol.2011.86","article-title":"Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms","volume":"24","author":"Brill","year":"2011","journal-title":"Mod Pathol"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/path.2974","article-title":"Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers","volume":"226","author":"Wetterskog","year":"2012","journal-title":"J Pathol"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.1158\/1078-0432.CCR-10-0463","article-title":"Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: incidence, variability, and clinicopathologic significance","volume":"16","author":"Mitani","year":"2010","journal-title":"Clin Cancer Res"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"7003","DOI":"10.1158\/1078-0432.CCR-11-1870","article-title":"Novel chromosomal rearrangements and break points at the t(6;9) in salivary adenoid cystic carcinoma: association with MYB-NFIB chimeric fusion, MYB expression, and clinical outcome","volume":"17","author":"Mitani","year":"2011","journal-title":"Clin Cancer Res"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1097\/PAS.0000000000000463","article-title":"Detection of MYB alterations and other immunohistochemical markers in primary cutaneous adenoid cystic carcinoma","volume":"39","author":"North","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/PAS.0b013e3182002777","article-title":"MYB expression and translocation in adenoid cystic carcinomas and other salivary gland tumors with clinicopathologic correlation","volume":"35","author":"West","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1016\/j.humpath.2014.07.013","article-title":"MYB-NFIB gene fusion in adenoid cystic carcinoma of the breast with special focus paid to the solid variant with basaloid features","volume":"45","author":"D\u2019Alfonso","year":"2014","journal-title":"Hum Pathol"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"E292","DOI":"10.1002\/lary.25356","article-title":"MYB rearrangement and clinicopathologic characteristics in head and neck adenoid cystic carcinoma","volume":"125","author":"Rettig","year":"2015","journal-title":"Laryngoscope"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nrc2439","article-title":"MYB function in normal and cancer cells","volume":"8","author":"Ramsay","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"7029","DOI":"10.1158\/0008-5472.CAN-11-1015","article-title":"MYB is essential for mammary tumorigenesis","volume":"71","author":"Miao","year":"2011","journal-title":"Cancer Res"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1097\/00000478-200308000-00002","article-title":"Microglandular adenosis with transition into adenoid cystic carcinoma of the breast","volume":"27","author":"Acs","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/PAS.0b013e31815a87e2","article-title":"Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma","volume":"32","author":"Khalifeh","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1038\/modpathol.2016.134","article-title":"Genetic events in the progression of adenoid cystic carcinoma of the breast to high-grade triple-negative breast cancer","volume":"29","author":"Fusco","year":"2016","journal-title":"Mod Pathol"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/PAS.0b013e31817f9790","article-title":"Most basal-like breast carcinomas demonstrate the same Rb-\/p16+ immunophenotype as the HPV-related poorly differentiated squamous cell carcinomas which they resemble morphologically","volume":"33","author":"Subhawong","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R21-20230922","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1530\/ERC-11-0345","article-title":"Oestrogen-induced genes in ductal carcinoma in situ: their comparison with invasive ductal carcinoma","volume":"19","author":"Ebata","year":"2012","journal-title":"Endocr Relat Cancer"},{"key":"R22-20230922","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/cncy.21693","article-title":"Usefulness of translocation-associated immunohistochemical stains in the fine-needle aspiration diagnosis of salivary gland neoplasms","volume":"124","author":"Foo","year":"2016","journal-title":"Cancer Cytopathol"},{"key":"R23-20230922","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/path.4717","article-title":"Overexpression of MYB drives proliferation of CYLD-defective cylindroma cells","volume":"239","author":"Rajan","year":"2016","journal-title":"J Pathol"},{"key":"R24-20230922","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/modpathol.2015.48","article-title":"Morphologically low-grade spiradenocarcinoma: a clinicopathologic study of 19 cases with emphasis on outcome and MYB expression","volume":"28","author":"van der Horst","year":"2015","journal-title":"Mod Pathol"},{"key":"R25-20230922","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/modpathol.3800658","article-title":"Immunophenotypic overlap between adenoid cystic carcinoma and collagenous spherulosis of the breast: potential diagnostic pitfalls using myoepithelial markers","volume":"19","author":"Rabban","year":"2006","journal-title":"Mod Pathol"},{"issue":"pt 2","key":"R26-20230922","first-page":"237","article-title":"Adenoid cystic carcinoma of the breast. A morphologically heterogeneous neoplasm","volume":"24","author":"Rosen","year":"1989","journal-title":"Pathol Annu"},{"key":"R27-20230922","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/path.2909","article-title":"The MYB-NFIB gene fusion-a novel genetic link between adenoid cystic carcinoma and dermal cylindroma","volume":"224","author":"Fehr","year":"2011","journal-title":"J Pathol"},{"key":"R28-20230922","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/path.4573","article-title":"Genomic landscape of adenoid cystic carcinoma of the breast","volume":"237","author":"Martelotto","year":"2015","journal-title":"J Pathol"},{"key":"R29-20230922","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/00000478-198307080-00002","article-title":"Microglandular adenosis of the breast. A clinicopathologic study of 11 cases with ultrastructural observations","volume":"7","author":"Tavassoli","year":"1983","journal-title":"Am J Surg Pathol"},{"key":"R31-20230922","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/path.4691","article-title":"Microglandular adenosis associated with triple-negative breast cancer is a neoplastic lesion of triple-negative phenotype harbouring TP53 somatic mutations","volume":"238","author":"Guerini-Rocco","year":"2016","journal-title":"J Pathol"},{"key":"R32-20230922","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1365-2559.2009.03432.x","article-title":"Microglandular adenosis or microglandular adenoma? A molecular genetic analysis of a case associated with atypia and invasive carcinoma","volume":"55","author":"Geyer","year":"2009","journal-title":"Histopathology"},{"key":"R33-20230922","doi-asserted-by":"crossref","first-page":"E115","DOI":"10.1111\/j.1365-2559.2012.04207.x","article-title":"Molecular evidence in support of the neoplastic and precursor nature of microglandular adenosis","volume":"60","author":"Geyer","year":"2012","journal-title":"Histopathology"},{"key":"R34-20230922","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/PAS.0b013e31818af361","article-title":"Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma","volume":"33","author":"Shin","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R35-20230922","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/modpathol.2016.161","article-title":"Genetic analysis of microglandular adenosis and acinic cell carcinomas of the breast provides evidence for the existence of a low-grade triple-negative breast neoplasia family","volume":"30","author":"Geyer","year":"2017","journal-title":"Mod Pathol"},{"key":"R36-20230922","first-page":"1099","article-title":"Microglandular adenosis: a non-obligate precursor of triple-negative breast cancer?","volume":"28","author":"Wen","year":"2013","journal-title":"Histol Histopathol"},{"key":"R37-20230922","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0046-8177(90)90235-W","article-title":"Infiltrating cribriform carcinoma of the breast: a distinctive clinicopathologic entity","volume":"21","author":"Venable","year":"1990","journal-title":"Hum Pathol"},{"key":"R38-20230922","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/PAS.0b013e318161d1a5","article-title":"Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: further evidence to support the concept of low nuclear grade breast neoplasia family","volume":"32","author":"Abdel-Fatah","year":"2008","journal-title":"Am J Surg Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000478-201707000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T22:18:46Z","timestamp":1695421126000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201707000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000000878","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]}}}